Fabulous to see @guildesports' @taysonFN win the Fortnite Champion Series All-Star Showdown last weekend.
#GILD talent has been a tad subdued on field the past couple of months, but three top 40 finishes (including first place ⬆️) in a major FNCS event is superb.
As per the Retweet ⬆️, this continued on-field success is critical for the commercial success of @guildesports over the long-term.
Evidently #GILD's set-up - the academy model, the personalised training, the player support - is working wonders.
FNCS victory this weekend...
2/6
...also comes right on the back of #GILD signing its fourth partnership deal in only 8 months - this one with Samsung, which followed Subway in March.
@guildesports has been signing sponsorship deals / partnerships at a rate of approx. one every two months - and those...
3/6
...partners seem to be larger, more globally recognised with each new signing. HUGELY encouraging developments for @guildesports#GILD.
It's important to bear in mind that the global gaming market is worth $175bn per annum; yet Esports sits at only $1bn pa. That's <0.6%.
4/6
The growth trajectory of Esports is going to be phenomenal over the next decade, IMO.
Quick relative valuation analysis (both public comps and precedent transaction) demonstrates that #GILD is already trading at a major discount to its peers (current fair value ~17-24p)...
5/6
But it's the LT growth prospects - as Esports explodes worldwide - that are so enticing.
@guildesports is building an empire from the ground up.
Rome wasn't built in a day; it'll take time for #GILD to become an established Tier 1 player.
But my word, what a flying start! 6/6
• • •
Missing some Tweet in this thread? You can try to
force a refresh
...construction ready. It's doubtful that any new production will be able to come online within the next two years - apart from the primary producers, #BMN and $LGO, expanding their operations.
@BushveldMin_Ltd owns two of only four primary production operations worldwide. 2/11
It is incredibly leveraged to the V price, which itself is illiquid and prone to exceptional moves.
With the global economic recovery driving steel output to all-time highs, demand for V (which is primarily used to strengthen steel) is steadily increasing.
ST trade: multiple purchases this week in #AVCT, av. 169p. Separate from core LT hold.
'Bad' news (i.e. slower build up in manufacturing capacity than envisaged by most; no commercial orders yet) now out of the way; potential for major and frequent positive news flow ahead. 1/12
Worst case scenario for #AVCT is that it'll sell 3m to 5m LFTs a month from August, for the next 3 years. That'll be £3m to £5m gross profit per month.
With clinical trials now commencing, assume annual cash burn increases to c.£30m.
@avacta's AVA6000 approved by MHRA. Superb news. First dosing 'around mid-year'; first data to come within 3-4 months after that.
A summary thread on the significance of AVA6000 - and #AVCT's pre CISION platform as a whole - to both the oncology industry and to AVCT itself. 1/10
In very basic terms, #AVCT's pre CISION chemotherapies are essentially reformulated versions of existing, approved chemotherapies that have been used on cancer patients for many years - decades, even.
The pre CISION tech is simply an attempt to improve the safety profile... 2/10
...of the chemo.
Most therapeutics going through clinical trials look for an improvement of at least 20% over the existing industry-standard drug. A 50% increase in efficacy would usually be considered an astonishing result.
In pre-clinical mouse models for #AVCT's AVA6000 3/10
By the end of next week, the Co intends to have put out a comprehensive TU.
Critically, it will include the sensitivity / specificity of its #COVID19 LFT for the first time. Analytical data collected so far suggests that it'll...1/14
...be the most accurate LFT in the world. However, it is not a given that analytical data will be replicated in the clinical data. Likely, but not definite.
Let's assume it IS replicated. #AVCT will CE Mark its LFT next month, and immediately begin selling it.
2/14
@avacta#AVCT does not have its own manufacturing capacity (yet). It will be contracting manufacturers to make its test.
The issue is - as is becoming more and more often the case in the world of micro-caps - people are buying companies like #AVCT without having first decided if it is a trade or an investment position.
I cover the importance of this distinction in my profile picture. 2/n
I myself am a trader, professionally, and actually hold very few long term investments. The volatility and lack of quality, accessible research renders AIM an excellent trading ground.
But @avacta#AVCT is an investment. In the next few weeks, it'll be submitting... 3/n
An extraordinary day. Firstly, fabulous initial data from Pfizer's vaccine, demonstrating it's 90% effective. An immense scientific breakthrough and a boon for humanity.
From an investment perspective (the raison d'être of this account!): a day of joy and misery, equally! 1/16
Global indices absolutely rocketed - 27/100 FTSE100 Cos ended the session at 10%+. Most sectors were up, whilst precious metals miners and #COVID19-centric stocks got obliterated. The latter group included treatment and testing stocks, and at home/online entertainment/living 2/16
Personally, my PF took an almighty spanking, owing to #AVCT being my largest position by a distance, and also having recently opened a position in #SNG.
A high quality vaccine was always the key risk to #COVID19 plays, but for me, that has always been a medium term risk. 3/16